Neurogene (NGNE) EBIT (2013 - 2026)
Neurogene (NGNE) posted EBIT of -$33.3 million for Q1 2026, down 21.14% on a QoQ basis from -$27.5 million in Q4 2025, and down 28.67% year-over-year from -$46.8 million in Q1 2025.
Neurogene (NGNE) EBIT (2013 - 2026) Analysis & Trends
Neurogene's EBIT history runs 14 years deep, the most recent figure standing at -$33.3 million for Q1 2026.
- Quarterly EBIT fell 28.67% year-over-year to -$33.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$110.8 million (down 23.41% YoY) and the FY2025 annual result came in at -$103.3 million, down 25.09% from the prior year.
- EBIT was -$33.3 million for Q1 2026 at Neurogene, down from -$27.5 million in the prior quarter.
- Across five years, EBIT topped out at -$11.7 million in Q4 2022 and bottomed at -$33.3 million in Q1 2026.
- A 5-year average of -$19.5 million and a median of -$18.8 million in 2024 frame the typical range for EBIT.
- Annual changes were most pronounced in 2022 — EBIT rose 23.09% — and 2024, when it slumped 59.84%.
- Neurogene's EBIT stood at -$11.7 million in 2022, then fell by 26.24% to -$14.7 million in 2023, then tumbled by 46.01% to -$21.5 million in 2024, then retreated by 27.97% to -$27.5 million in 2025, then fell by 21.14% to -$33.3 million in 2026.
- Business Quant data shows NGNE's EBIT at -$33.3 million in Q1 2026, -$27.5 million in Q4 2025, and -$23.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | -33.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.35 Mn |
| Dec 31, 2025 | -27.53 Mn |
| Sep 30, 2025 | -23.80 Mn |
| Jun 30, 2025 | -26.08 Mn |
| Mar 31, 2025 | -25.92 Mn |
| Dec 31, 2024 | -21.51 Mn |
| Sep 30, 2024 | -22.18 Mn |
| Jun 30, 2024 | -20.13 Mn |
| Mar 31, 2024 | -18.78 Mn |
| Dec 31, 2023 | -14.73 Mn |
| Sep 30, 2023 | -15.22 Mn |
| Jun 30, 2023 | -12.60 Mn |
| Mar 31, 2023 | -13.04 Mn |
| Dec 31, 2022 | -11.67 Mn |
| Sep 30, 2022 | -13.61 Mn |
| Jun 30, 2022 | -15.87 Mn |
| Mar 31, 2022 | -15.37 Mn |
| Dec 31, 2021 | -15.17 Mn |
| Sep 30, 2021 | -15.45 Mn |
| Jun 30, 2021 | -15.12 Mn |